An integrated approach to panic prevention targeting the empirically supported risk factors of smoking and anxiety sensitivity: Theoretical basis and evidence from a pilot project evaluating feasibility and short-term efficacy

An integrated approach to panic prevention targeting the empirically supported risk factors of smoking and anxiety sensitivity: Theoretical basis and evidence from a pilot project evaluating feasibility and short-term efficacy
复制标题

DOI:
10.1016/j.janxdis.2008.01.005
复制
发表时间:
2008-10-01
影响因子:
10.3
通讯作者:
Schmidt, Norman B.
Schmidt, Norman B.
中科院分区:
医学2区
文献类型:
--
作者:
Feldner, Matthew T.;Zvolensky, Michael J.;Schmidt, Norman B.

文献摘要

被引文献

相似文献

与有针对性的预防的风险降低模型相一致,本研究对第一代恐慌预防计划的可行性和短期疗效进行了试点和经验评估,该计划针对恐慌发展的两个可塑性风险因素-焦虑敏感性和每日吸烟。由高水平的焦虑敏感性和当前每日吸烟定义的高风险队列的成员(n = 96)被随机分配到(1)一个疗程的干预,重点是近端增加戒烟动机和降低焦虑敏感性,以远端防止恐慌的发展或(2)健康信息控制条件的可比长度。参与者被跟踪了6个月。与假设一致,那些在治疗条件下表现出降低焦虑敏感性,这种效果在整个随访期间保持。有限的证据还表明,干预措施增加了戒烟的动力。我们讨论了如何在未来修改这一预防方案,以提高其作为第二代大规模结局评价的一部分的效果。(C)2008爱思唯尔有限公司保留所有权利。
Consistent with a risk reduction model of targeted prevention, the present investigation piloted and empirically evaluated the feasibility and short-term efficacy of a first-generation panic prevention program that targeted two malleable risk factors for panic development-anxiety sensitivity and daily cigarette smoking. Members of a high risk cohort, defined by high levels of anxiety sensitivity and current daily smoking (n = 96), were randomly assigned to either (1) a one session intervention focused on proximally increasing motivation to quit smoking and reducing anxiety sensitivity to distally prevent the development of panic or (2) a health information control condition of comparable length. Participants were followed for 6 months. Consistent with hypotheses, those in the treatment condition showed reduced anxiety sensitivity and this effect was maintained across the follow-up period. Limited evidence also suggested the intervention increased motivation to quit smoking. We discuss how this prevention protocol can be modified in the future to enhance its effects as part of second-generation larger-scale outcome evaluations. (C) 2008 Elsevier Ltd. All rights reserved.